DRMAW vs GIS
Dermata Therapeutics Inc. Warrant (DRMAW) versus General Mills Inc (GIS) — a side-by-side from cached financials, not a winner call.
Dermata Therapeutics Inc. Warrant (DRMAW) common stock listed on NASDAQ.
General Mills Inc (GIS) is a packaged foods company listed on NYSE.
DRMAW does not have a complete income-statement cache yet.
Latest reported GIS revenue for 2026-05-31 was $18.42B. Net income was -$87.6M. Revenue was up 304.4% from 2025-05-25 to 2026-05-31. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
DRMAW currently screens at market cap $0. GIS currently screens at market cap $17.80B and trailing P/E 8.2.
Not investment advice. Open the DRMAW and GIS stock pages for the full models.
Not investment advice.